Compare Mutual Funds

Pros

-

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
6/11
10/11
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

5 Years

14 Years

Fund AUM

₹266 Cr

₹9166 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.92%

1%

Exit Load

0.5%

1%

Benchmark Index

Nifty Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

38

40

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.96%)
  2. Divi's Laboratories Ltd(9.51%)
  3. Apollo Hospitals Enterprise Ltd(5.45%)
  4. Dr Reddy's Laboratories Ltd(4.78%)
  5. Torrent Pharmaceuticals Ltd(4.78%)
  1. Sun Pharmaceuticals Industries Ltd(11.71%)
  2. Divi's Laboratories Ltd(7.1%)
  3. Lupin Ltd(6.17%)
  4. Cipla Ltd(6.01%)
  5. Dr Reddy's Laboratories Ltd(5.45%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(97.85%)
  2. Basic Materials(2.15%)

Health

(100%)

Equity %

99.29%

97.3%

Debt %

-

-

P/E

43.22

37.98

P/B

6.1

5.6

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

2.3%

1.64%

3-Month Return

0.41%

-0.65%

6-Month Return

12.46%

8.75%

1-Year Return

11.52%

10.54%

3-Year Return

20.71%

18.88%

5-Year Return

-

14.54%

Sharpe

0.85

0.83

Alpha

-0.47

-2.19

Beta

0.96

0.89

Standard Deviation

16.51

14.87

Information Ratio

-0.26

-1.14

Description

ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Nilay Dalal, Animesh Singh

Sailesh Raj Bhan, Amber Singhania, Kinjal Desai

Most Popular Comparisons